Glooko and Innovation Zed today announced a strategic partnership to develop and deploy digital companion apps for injectable therapies.
Palo Alto, California-based Glooko’s current platforms enable patients to share diabetes data with healthcare providers. That includes blood glucose readings, insulin doses, food and carbs, exercise activity, blood pressure and weight.
Ireland-based Innovation Zed develops insulin dosing technology, including the InsulCheck DOSE add-on device for pen injectors. The company featured on our 2023 list of drug delivery innovations you should know.
The companies plan to work together on companion apps with the adaptive Dose platform hardware add-on technology. They aim to revolutionize the management of injectable medications with comprehensive connectivity and data capture solutions for dosing, storage and injection techniques.
“We are excited to partner with Innovation Zed to bring this cutting-edge digital companion system to market,” said Mike Alvarez, Glooko CEO. “This collaboration will enable us to provide comprehensive support for patients and their healthcare providers, ultimately enhancing the treatment experience and improving outcomes. This partnership, combined with our ongoing platform development, reflects Glooko’s continued focus on increasing the benefits delivered to patients and clinics.”
More about the partnership between Glooko and Innovation Zed
The companies say their collaboration aims to address the significant challenges of injectable therapies. Together, they hope to deliver a comprehensive digital solution that supports patients and healthcare providers.
This digital companion system from the two companies could seamlessly integrate hardware and software. The companies want it to work with the Glooko platform to capture and analyze critical information related to injectable therapies from the Innovation Zed Dose platform.
With the combined technologies, the companies expect improved adherence and optimized therapy outcomes. They also believe it could enhance safety and increase patient confidence while streamlining data management.
Leveraging the Glooko platform’s reach offers industry partners a launchpad into key markets, the companies say.
“Our partnership with Glooko represents a significant step forward in the integration of our smart drug delivery solutions with a leading digital health platform,” said Dean Minnock, Innovation Zed CEO. “Together, we can offer unparalleled support to patients and healthcare providers, improving the management of injectable therapies worldwide.”
